(Q33360846)

26 July 2017

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer (English)

1 reference

26 July 2017

0 references

1 reference

S A Hussain

1

1 reference

26 July 2017

D D Stocken

2

1 reference

26 July 2017

D R Peake

3

1 reference

26 July 2017

J G Glaholm

4

1 reference

26 July 2017

A Zarkar

5

1 reference

26 July 2017

D M A Wallace

6

1 reference

26 July 2017

N D James

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

British Journal of Cancer

26 July 2017

1 reference

26 July 2017

90

1 reference

26 July 2017

2106-2111

1 reference

26 July 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601852

26 July 2017

0 references

cites work

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Organ preservation strategies in bladder cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Invasive bladder cancer: organ preservation by radiochemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Management of invasive bladder cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Radical cystectomy for stage T3b bladder cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

The combination of cis-platin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409507

A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601852

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601852

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601852

Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601852

Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors

21 January 2018

1 reference

12 December 2020

Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma

1 reference

12 December 2020

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study

1 reference

12 December 2020

Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study

1 reference

12 December 2020

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 reference

12 December 2020

A phase II study of 5-fluorouracil and high dose folinic acid in cisplatin-refractory metastatic bladder cancer

1 reference

12 December 2020

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research

1 reference

12 December 2020

Long–Term Risk of Salvage Cystectomy after Radiotherapy for Muscle–Invasive Bladder Cancer

1 reference

12 December 2020

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

1 reference

12 December 2020

Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy

1 reference

12 December 2020

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

1 reference

12 December 2020

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

12 December 2020

Dimensions Publication ID

Identifiers

DOI

10.1038/SJ.BJC.6601852

0 references

0 references

1 reference

26 July 2017

1 reference